Skip to main content

Houlihan Capital

Enhancing Valuation Confidence: The Role of Positive Assurance in Portfolio Valuation

Profile of a woman at a computer in a blue-toned Houlihan Capital banner with the headline 'Enhancing Valuation Confidence'.

When the Mark Gets Questioned  The moment arrives in different forms. An auditor returns to a fair value conclusion with a request for additional support on the methodology applied to a Level 3 position. An institutional limited partner, conducting its own due diligence on the fund, asks how the manager arrived at a particular mark, and the answer that seemed […]

Preparing for a Sale: What to Expect from a Sell-Side Advisor

Banner for Houlihan Capital: logo and headline 'Preparing for a sale: What to expect from a sell-side advisor' over a blue abstract office background.

Framing the Decision to Sell  For many founder-owned businesses, a sale represents one of the most significant financial and strategic decisions an owner will make. It is often the culmination of years, if not decades, of effort, risk-taking, and reinvestment.  Despite its importance, most founders go through the process only once. Unlike operating decisions made daily within […]

Cannabis Rescheduling Is Here. What It Means for Business Valuations.

Banner image for Houlihan Capital about cannabis rescheduling and business valuations, featuring cannabis leaves and a dark overlay with the headline text.

On April 22, 2026, the Acting Attorney General issued a final order reclassifying FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act. A formal DEA hearing on broader cannabis rescheduling is scheduled to begin June 29, 2026.  This is the most consequential shift in federal marijuana […]